Definitive Contract W81XWH17C0200

This is a definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Humacyte Global Inc., a for-profit manufacturer, for the "Vascular Interventions/Innovations and Therapeutic Advances (VITA): Bioengineered Grafts for Peripheral Vascular Disease" program. The contract, which has a potential value of $1,570,756.00, is for a base period from November 15, 2013 to November 14, 2014, with a completion...

The Department of the Army Medical Command awarded a $148,203.61 Small Business Innovation Research (SBIR) Phase I contract to Haima Therapeutics LLC, a woman-owned small business, for research and development of a nanotechnology-enabled biosynthetic whole-blood surrogate for hemostatic resuscitation. This contract supports the Congressionally Directed Medical Research Programs' Combat Readiness-Medical Research Program under a Rapid Development and Translational Research Award. Additionally,...

This federal contract award is for the provision of HUMAN CELLS OR TISSUES INTENDED FOR IMPLANTATION, TRANSPLANTATION, INFUSION, OR TRANSFER INTO HUMAN RECIPIENT. The contract has a ceiling value of $16,850.00 and was awarded on July 26, 2024, with a final completion date of September 30, 2024. The contract is a firm fixed-price purchase order awarded to Miscellaneous Foreign Awardees, a for-profit organization registered in the System for Award Management (SAM). Miscellaneous Foreign Awardees...

This is a $140,910.00 firm-fixed-price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Sim-Vivo LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract supports a Phase I SBIR effort, indicated by the "SBIR DHP PHASE I PROPOSAL H161-011-0101" description. The contract was awarded on September 30, 2016 with a completion date of July 29, 2017. The contract has a "Total Small Business" set-aside designation.

This $824,998.50 firm-fixed-price definitive contract was awarded by the Defense Health Agency to Wake Forest University Health Sciences (WFUHS), a leading academic medical center, to develop a human organ tissue equivalent (OTE) platform with microfluidic technology that represents the lung and gut with integrated microvasculature. This unrestricted contract supports advanced biomedical research and development to create a tissue-engineered model that mimics the physiological functions of the...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, on March 20, 2024. The $19,794.24 contract is for the delivery of 1,200 units of HUMATE-P (Antihemophilic Factor/von Willebrand Factor Complex (Human)) to be completed by April 10, 2024. The order is placed under DMS Pharmaceutical Group's $4,999,999 indefinite delivery vehicle (IDV) contract number SPE2DB22D9353 with DLA, which...

This firm fixed-price purchase order, awarded by the Defense Health Agency, provides human tissue for reconstructive surgery. The $46,280 contract has a completion date of September 30, 2024 and was awarded on September 3, 2024. The prime contractor is Miscellaneous Foreign Awardees, a for-profit subsidiary of Engie Services Zuid B.V. that provides facilities operations, maintenance, and construction services to various federal agencies, with a focus on supporting diplomatic facilities and...

This is a $3,030.82 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of HUMIRA(CF) PEN CRHN-UC-HS 80MGS, a pharmaceutical product. The contract has an ultimate completion date of May 8, 2024. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...

This is a $2,948.67 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of HUMIRA 40 MG/0.8 ML syringes to support military healthcare programs. The contract has a completion date of July 10, 2024 and was awarded on July 9, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...

<p>This is a firm fixed price purchase order contract awarded by the Defense Health Agency, a defense agency, to CM Medical Services, LLC, a veteran-owned small business, for the replacement of heart tissues (CMD-0007) on August 4, 2016. The contract has a ceiling value of $89,293.89 and a completion date of August 10, 2016. The place of performance is Bethesda, Maryland. This contract was not set aside for any particular business size or type.</p>